Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 11
Submit an article Journal homepage
188
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Role of high acquisition flow cytometry in the detection of marrow involvement in patients with extramedullary B cell non-Hodgkins lymphoma: a comparison with marrow aspirate cytology, trephine biopsy, and PET

Thulasi Raman Ramalingama Department of Hematology, Apollo Cancer Centre, Chennai, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8332-9562
ORCID Icon,
Anurekha Muthua Department of Hematology, Apollo Cancer Centre, Chennai, India
,
Archana Lakshmananb Department of Histopathology, Apollo Cancer Centre, Chennai, India
,
Swetha Narlab Department of Histopathology, Apollo Cancer Centre, Chennai, India
,
Annapurneswari Subramanyanb Department of Histopathology, Apollo Cancer Centre, Chennai, India
,
Shelley Simonc Department of Nuclear Medicine, Apollo Cancer Centre, Chennai, India
,
Jayaraj Govindarajd Department of Radiology, Apollo Cancer Centre, Chennai, India
,
Lakshman Vaidhyanathana Department of Hematology, Apollo Cancer Centre, Chennai, India
,
Jose Easowe Department of Medical Oncology, Blood and Marrow Transplantation, Apollo Cancer Centre, Chennai, India
&
Thirumalairaj Rajaf Department of Medical Oncology, Apollo Cancer Centre, Chennai, India
 show all
Pages 2589-2596 | Received 17 Jan 2022, Accepted 13 Jun 2022, Published online: 12 Jul 2022

References

  • Sah SP, Matutes E, Wotherspoon AC, et al. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol. 2003;56(2):129–132.
  • Chauhan S, Pradhan S, Mohanty R, et al. Bone marrow trephine biopsies: a single centre experience in Eastern India. Arch Med Health Sci. 2017;5:34–38.
  • Ujjani CS, Hill EM, Wang H, et al. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Br J Haematol. 2016;174(3):410–416.
  • Adams HJA, Nievelstein RAJ, Kwee TC. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev. 2015;29(6):417–425.
  • Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol. 2001;12(6):825–830.
  • Seegmiller AC, Hsi ED, Craig FE. The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms. Cytometry B Clin Cytom. 2019;96(1):20–29.
  • Scott GD, Lau HD, Kurzer JH, et al. Flow immunophenotyping of benign lymph nodes sampled by FNA: representative with diagnostic pitfalls. Cancer Cytopathol. 2018;126(9):797–808.
  • Reichard KK, McKenna RW, Kroft SH. Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues. A four-color flow cytometric study. Am J Clin Pathol. 2003;119(1):130–136.
  • Hong J, Kim JY, Ahn HK, et al. Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma. Support Care Cancer. 2013;21(4):1145–1152.
  • Della Starza I, Chiaretti S, De Propris MS, et al. Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances. Front Oncol. 2019;9:726.
  • Buldini B, Maurer-Granofszky M, Varotto E, et al. Flow-cytometric monitoring of minimal residual disease in pediatric patients with acute myeloid leukemia: recent advances and future strategies. Front Pediatr. 2019;7:412.
  • Böttcher S. Flow cytometric MRD detection in selected mature B-cell malignancies. In: Küppers R, editors. Lymphoma. Methods in molecular biology. New York (NY): Humana Press; 1956.
  • Del Giudice I, Raponi S, Della Starza I, et al. Minimal residual disease in chronic lymphocytic leukemia: a new goal? Front Oncol. 2019;9:689.
  • Soh KT, Wallace PK. Monitoring of measurable residual disease in multiple myeloma by multiparametric flow cytometry. Curr Protoc Cytom. 2019;90(1):e63.
  • Dold SM, Riebl V, Wider D, et al. Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma. Haematologica. 2020;105(10):e523.
  • Shi Y-F, Li X-H, Song Y-Q, et al. Involvement of bone marrow in lymphoma: pathological investigation in a single-center from Northern China. Int J Clin Exp Pathol. 2015;8(6):7102–7111.
  • Duggan PR, Easton D, Luider J, et al. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer. 2000;88(4):894–899.
  • Merli M, Arcaini L, Boveri E, et al. Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. Eur J Haematol. 2010;85(5):405–415.
  • Kim B, Lee S-T, Kim H-J, et al. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma. Ann Lab Med. 2015;35(2):187–193.
  • Martín-Moro F, Piris-Villaespesa M, Marquet-Palomanes J, et al. Bone marrow infiltration by flow cytometry at diffuse large B-cell lymphoma NOS diagnosis implies worse prognosis without considering bone marrow histology. Cytometry B Clin Cytom. 2020;98(6):525–528.
  • Hao B, Zhao L, Luo N-N, et al. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18 F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy. BMC Cancer. 2018;18(1):1192.
  • Chen-Liang T-H, Martin-Santos T, Jerez A, et al. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Am J Hematol. 2015;90(8):686–690.
  • Chrysi G, Zaragoza-Infante Laura I, Anastasia C, et al. Understanding monoclonal B cell lymphocytosis: an interplay of genetic and microenvironmental factors. Front Oncol. 2021;11:769612.
  • Park Y, Park BB, Jeong JY, et al. Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party. Korean J Intern Med. 2016;31(6):1030–1041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.